338 related articles for article (PubMed ID: 7150397)
1. Blood changes in sex steroid hormone users. Circulating immune complexes induced by estrogens and progestogens and their relation to vascular thrombosis.
Beaumont V; Delplanque B; Lemort N; Beaumont JL
Atherosclerosis; 1982 Sep; 44(3):343-53. PubMed ID: 7150397
[TBL] [Abstract][Full Text] [Related]
2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
3. [Vascular thrombosis in synthetic estrogen-progestogen users: an immune mechanism (author's transl)].
Beaumont V; Beaumont JL
Nouv Presse Med; 1981 Feb; 10(7):503-7. PubMed ID: 7232196
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: results from 1318 cases.
Beaumont V; Lemort N; Beaumont JL
Eur Heart J; 1991 Nov; 12(11):1219-24. PubMed ID: 1782953
[TBL] [Abstract][Full Text] [Related]
5. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
[TBL] [Abstract][Full Text] [Related]
6. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard O
BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
[TBL] [Abstract][Full Text] [Related]
7. Smoking and use of oral contraceptives: impact on thrombotic diseases.
Lidegaard O
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
[TBL] [Abstract][Full Text] [Related]
8. Oral contraception, circulating immune complexes, antiethinylestradiol antibodies, and thrombosis.
Beaumont V; Lemort N; Beaumont JL
Am J Reprod Immunol (1980); 1982 Feb; 2(1):8-12. PubMed ID: 7091494
[TBL] [Abstract][Full Text] [Related]
9. Effects of estrogens and progestogens on lipid metabolism.
Oster P; Arab L; Kohlmeier M; Mordasini R; Schellenberg B; Schlierf G
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):773-5. PubMed ID: 7065057
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
Beaumont V; Malinow MR; Sexton G; Wilson D; Lemort N; Upson B; Beaumont JL
Atherosclerosis; 1992 Jun; 94(2-3):147-52. PubMed ID: 1632868
[TBL] [Abstract][Full Text] [Related]
11. Progestogens in cardiovascular diseases: an introduction to the epidemiologic data.
Mann JI
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):752-7. PubMed ID: 7065056
[TBL] [Abstract][Full Text] [Related]
12. [Combined contraceptives and cardiovascular risk].
Belaisch J; Hommais-loufrani B
Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
14. [Vascular thrombosis related to oral contraceptives and antiethinylestradiol antibodies--epidemiology and prevention (author's transl)].
Beaumont V; Beaumont JL
Ther Umsch; 1982 Feb; 39(2):109-13. PubMed ID: 6461942
[TBL] [Abstract][Full Text] [Related]
15. [Immunological changes and vascular thrombosis induced by oestro-progestative hormones (author's transl)].
Beaumont V; Beaumont JL
Contracept Fertil Sex (Paris); 1982 Feb; 10(2):75-9. PubMed ID: 12311460
[TBL] [Abstract][Full Text] [Related]
16. Contraceptive Steroids, age, and the cardiovascular system.
Plunkett ER
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):747-51. PubMed ID: 7065055
[TBL] [Abstract][Full Text] [Related]
17. Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study.
Kay CR
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):762-5. PubMed ID: 6801981
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and the cobalamin (vitamin B12) metabolism.
Hjelt K; Brynskov J; Hippe E; Lundström P; Munck O
Acta Obstet Gynecol Scand; 1985; 64(1):59-63. PubMed ID: 3976378
[TBL] [Abstract][Full Text] [Related]
19. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
[TBL] [Abstract][Full Text] [Related]
20. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
